These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38317868)

  • 21. Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy.
    Mohan A; Saxena S; Kaur A; Ali W; Akduman L
    Mol Vis; 2021; 27():429-437. PubMed ID: 34267498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association of choroidal thickness with diabetic retinopathy at different stages].
    Wang S; Lin S; Zheng Y; Di F; Cao X; Liu C; Yang J
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2584-8. PubMed ID: 26711604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin use and the risk of progression to vision threatening diabetic retinopathy.
    Meer E; Bavinger JC; Yu Y; Hua P; McGeehan B; VanderBeek BL
    Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):652-660. PubMed ID: 35253307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The impact of diabetic retinopathy on vision-related quality of life].
    Zang B; Rong SS; Ding XX; Zou B; Zang DX; Wang Y; Xu KM; Feng D; Li D
    Zhonghua Yan Ke Za Zhi; 2022 Oct; 58(10):760-768. PubMed ID: 36220647
    [No Abstract]   [Full Text] [Related]  

  • 25. Severity of diabetic retinopathy and health-related quality of life: the Los Angeles Latino Eye Study.
    Mazhar K; Varma R; Choudhury F; McKean-Cowdin R; Shtir CJ; Azen SP;
    Ophthalmology; 2011 Apr; 118(4):649-55. PubMed ID: 21035872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial haplogroups are associated with severity of diabetic retinopathy.
    Estopinal CB; Chocron IM; Parks MB; Wade EA; Roberson RM; Burgess LG; Brantley MA; Samuels DC
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5589-95. PubMed ID: 25118268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy.
    Wykoff CC; Khurana RN; Nguyen QD; Kelly SP; Lum F; Hall R; Abbass IM; Abolian AM; Stoilov I; To TM; Garmo V
    Diabetes Care; 2021 Mar; 44(3):748-756. PubMed ID: 33472864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
    Bressler SB; Liu D; Glassman AR; Blodi BA; Castellarin AA; Jampol LM; Kaufman PL; Melia M; Singh H; Wells JA;
    JAMA Ophthalmol; 2017 Jun; 135(6):558-568. PubMed ID: 28448655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia and Diabetic Kidney Disease Had Joint Effect on Diabetic Retinopathy Among Patients With Type 2 Diabetes.
    Wang J; Xin X; Luo W; Wang R; Wang X; Si S; Mo M; Shao B; Wang S; Shen Y; Chen X; Yu Y
    Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):25. PubMed ID: 33351059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.
    Maturi RK; Glassman AR; Josic K; Antoszyk AN; Blodi BA; Jampol LM; Marcus DM; Martin DF; Melia M; Salehi-Had H; Stockdale CR; Punjabi OS; Sun JK;
    JAMA Ophthalmol; 2021 Jul; 139(7):701-712. PubMed ID: 33784735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-reported healthcare utilization by adults with diabetic retinopathy in the United States.
    Willis JR; Doan QV; Gleeson M; Haskova Z; Ramulu P; Morse L; Cantrell RA
    Ophthalmic Epidemiol; 2018; 25(5-6):365-372. PubMed ID: 29958092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy.
    Chen L; Zhang X; Wen F
    Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1059-1065. PubMed ID: 29626228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
    Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
    IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
    Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
    Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM
    Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining Risk Factors That Affect Progression in Patients with Nonproliferative Diabetic Retinopathy.
    Chen DJ; Kuo JC; Wright AJ; Chuang AZ; Chan W; Feldman RM; Crowell EL
    J Ophthalmol; 2021; 2021():6064525. PubMed ID: 34888097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of diabetic retinopathy severity scales with frequency and surface area of diabetic retinopathy lesions.
    Esmaeilkhanian H; Liu H; Fasih-Ahmed S; Gnanaraj R; Verma A; Oncel D; He Y; Nittala MG; Attiku Y; Kadomoto S; Corradetti G; Velaga SB; Tsui I; Prasad P; Li X; Li X; Jiang SC; Choudhry N; Jayadev C; Sadda S
    Graefes Arch Clin Exp Ophthalmol; 2023 Nov; 261(11):3165-3176. PubMed ID: 37392262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors and Outcomes of Delayed Presentation of Diabetic Retinopathy Patients to a County Hospital.
    Lu VI; Patnaik JL; Scott RA; Lynch AM; Smith JM; Mandava N; Manoharan N
    Transl Vis Sci Technol; 2023 Sep; 12(9):8. PubMed ID: 37676677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Ultra-Widefield Angiography and Diabetic Retinopathy Severity: An Assessment of Panretinal Leakage Index, Ischemic Index and Microaneurysm Count.
    Ehlers JP; Jiang AC; Boss JD; Hu M; Figueiredo N; Babiuch A; Talcott K; Sharma S; Hach J; Le T; Rogozinski A; Lunasco L; Reese JL; Srivastava SK
    Ophthalmology; 2019 Nov; 126(11):1527-1532. PubMed ID: 31383482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.